BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15978614)

  • 1. SIH--a novel lipophilic iron chelator--protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death.
    Simůnek T; Boer C; Bouwman RA; Vlasblom R; Versteilen AM; Sterba M; Gersl V; Hrdina R; Ponka P; de Lange JJ; Paulus WJ; Musters RJ
    J Mol Cell Cardiol; 2005 Aug; 39(2):345-54. PubMed ID: 15978614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity.
    Hašková P; Kovaříková P; Koubková L; Vávrová A; Macková E; Simůnek T
    Free Radic Biol Med; 2011 Feb; 50(4):537-49. PubMed ID: 21147217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cytoprotective and toxic properties of iron chelator SIH, prochelator BSIH and their degradation products.
    Jansová H; Bureš J; Macháček M; Hašková P; Jirkovská A; Roh J; Wang Q; Franz KJ; Kovaříková P; Šimůnek T
    Toxicology; 2016 Mar; 350-352():15-24. PubMed ID: 27046792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralysosomal iron chelation protects against oxidative stress-induced cellular damage.
    Kurz T; Gustafsson B; Brunk UT
    FEBS J; 2006 Jul; 273(13):3106-17. PubMed ID: 16762036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyl and ethyl ketone analogs of salicylaldehyde isonicotinoyl hydrazone: novel iron chelators with selective antiproliferative action.
    Macková E; Hrušková K; Bendová P; Vávrová A; Jansová H; Hašková P; Kovaříková P; Vávrová K; Simůnek T
    Chem Biol Interact; 2012 May; 197(2-3):69-79. PubMed ID: 22521999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH).
    Sterba M; Popelová O; Simůnek T; Mazurová Y; Potácová A; Adamcová M; Guncová I; Kaiserová H; Palicka V; Ponka P; Gersl V
    Toxicology; 2007 Jun; 235(3):150-66. PubMed ID: 17459556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury.
    Bendova P; Mackova E; Haskova P; Vavrova A; Jirkovsky E; Sterba M; Popelova O; Kalinowski DS; Kovarikova P; Vavrova K; Richardson DR; Simunek T
    Chem Res Toxicol; 2010 Jun; 23(6):1105-14. PubMed ID: 20521781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of novel salicylaldehyde isonicotinoyl hydrazone (SIH) analogs: iron chelation, anti-oxidant and cytotoxic properties.
    Potůčková E; Hrušková K; Bureš J; Kovaříková P; Špirková IA; Pravdíková K; Kolbabová L; Hergeselová T; Hašková P; Jansová H; Macháček M; Jirkovská A; Richardson V; Lane DJ; Kalinowski DS; Richardson DR; Vávrová K; Šimůnek T
    PLoS One; 2014; 9(11):e112059. PubMed ID: 25393531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and initial in vitro evaluations of novel antioxidant aroylhydrazone iron chelators with increased stability against plasma hydrolysis.
    Hruskova K; Kovarikova P; Bendova P; Haskova P; Mackova E; Stariat J; Vavrova A; Vavrova K; Simunek T
    Chem Res Toxicol; 2011 Mar; 24(3):290-302. PubMed ID: 21214215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,6-Dihydroxybenzaldehyde Analogues of the Iron Chelator Salicylaldehyde Isonicotinoyl Hydrazone: Increased Hydrolytic Stability and Cytoprotective Activity against Oxidative Stress.
    Jansová H; Kubeš J; Reimerová P; Štěrbová-Kovaříková P; Roh J; Šimůnek T
    Chem Res Toxicol; 2018 Nov; 31(11):1151-1163. PubMed ID: 30395451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against hydrogen peroxide-mediated cytotoxicity in Friedreich's ataxia fibroblasts using novel iron chelators of the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone class.
    Lim CK; Kalinowski DS; Richardson DR
    Mol Pharmacol; 2008 Jul; 74(1):225-35. PubMed ID: 18424550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chelation of lysosomal iron protects against ionizing radiation.
    Berndt C; Kurz T; Selenius M; Fernandes AP; Edgren MR; Brunk UT
    Biochem J; 2010 Dec; 432(2):295-301. PubMed ID: 20846118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury.
    Jansová H; Macháček M; Wang Q; Hašková P; Jirkovská A; Potůčková E; Kielar F; Franz KJ; Simůnek T
    Free Radic Biol Med; 2014 Sep; 74():210-21. PubMed ID: 24992833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin.
    Kaiserová H; den Hartog GJ; Simůnek T; Schröterová L; Kvasnicková E; Bast A
    Br J Pharmacol; 2006 Dec; 149(7):920-30. PubMed ID: 17031387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone.
    Simůnek T; Sterba M; Popelová O; Kaiserová H; Adamcová M; Hroch M; Hasková P; Ponka P; Gersl V
    Br J Pharmacol; 2008 Sep; 155(1):138-48. PubMed ID: 18536744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serofendic acid, a novel substance extracted from fetal calf serum, protects against oxidative stress in neonatal rat cardiac myocytes.
    Takeda T; Akao M; Matsumoto-Ida M; Kato M; Takenaka H; Kihara Y; Kume T; Akaike A; Kita T
    J Am Coll Cardiol; 2006 May; 47(9):1882-90. PubMed ID: 16682316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrogen compounds prevent h9c2 myoblast oxidative stress-induced mitochondrial dysfunction and cell death.
    Silva JP; Sardão VA; Coutinho OP; Oliveira PJ
    Cardiovasc Toxicol; 2010 Mar; 10(1):51-65. PubMed ID: 20119745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial glutathione protects against cell death induced by oxidative and nitrative stress in astrocytes.
    Muyderman H; Wadey AL; Nilsson M; Sims NR
    J Neurochem; 2007 Aug; 102(4):1369-82. PubMed ID: 17484727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor delta (PPARdelta) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis.
    Pesant M; Sueur S; Dutartre P; Tallandier M; Grimaldi PA; Rochette L; Connat JL
    Cardiovasc Res; 2006 Feb; 69(2):440-9. PubMed ID: 16337160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigallocatechin gallate protects H9c2 cardiomyoblasts against hydrogen dioxides- induced apoptosis and telomere attrition.
    Sheng R; Gu ZL; Xie ML; Zhou WX; Guo CY
    Eur J Pharmacol; 2010 Sep; 641(2-3):199-206. PubMed ID: 20553906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.